
In 2016 was created Bioverge, which is appeared as Corporate Investor.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Bioverge, startups are often financed by Venture University, VU Venture Partners, Thomas Glocer. The meaningful sponsors for the fund in investment in the same round are Thiel Capital, Techammer, Phil Libin.
We can highlight the next thriving fund investment areas, such as Artificial Intelligence, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight OccamzRazor. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.
The fund was created by Neil Littman, Rick Gibb.
The important activity for fund was in 2019. The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars.
Related Funds
Fund Name | Location |
2GIS | Novosibirsk, Novosibirsk Oblast, Russia |
Dijian Trading | China, Guangdong, Tianjin |
Essential Investment Partners | - |
French Public Bank of Investment | - |
G Street Capital | China, Guangdong, Shenzhen |
High Ground Capital | Beijing, Beijing, China |
Hunch Ventures | Delhi, India, New Delhi |
Iroquois Capital | Nashville, Tennessee, United States |
MAD Ventures GmbH | Austria, Innsbruck, Tirol |
Osmington | Canada, Ontario, Toronto |
Peak Opportunity Partners | New York, New York, United States |
Sand 9 | Cambridge, Massachusetts, United States |
Sandvine | Canada, Ontario, Waterloo |
Silver Lake | California, Menlo Park, United States |
SummitVision Capital, LLC | California, San Francisco, United States |
TD Veen | Norway, Rogaland, Stavanger |
The Japan Research Institute | Japan, Setagaya |
Tofino Capital | District of Columbia, United States, Washington |
Zhejiang Lusheng Shipen Keji Co., Ltd | China, Ningbo, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
NutriSense | $3M | 13 Sep 2021 | Chicago, Illinois, United States | ||
BioROSA Technologies | 15 Jul 2021 | Massachusetts, United States | |||
Enveda Biosciences | 15 Jun 2021 | San Francisco, California, United States | |||
Juno Diagnostics | 25 May 2021 | San Diego, California, United States | |||
HepaTx | 20 May 2021 | Palo Alto, California, United States | |||
Elucid | $10M | 10 May 2021 | Boston, Massachusetts, United States | ||
Elucid | 17 Mar 2021 | Boston, Massachusetts, United States | |||
iviva medical | 03 Mar 2021 | Beverly, Massachusetts, United States | |||
Ancilia Biosciences | 14 Dec 2020 | - |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.